910 Clopper Road, Suite 205 N
Gaithersburg MD 20878
Lentigen Technology, Inc. is a privately owned diversified biologics company focused on the use of lentiviral vectors for the development of breakthrough technologies for human disease including novel, cell therapeutics, protein therapcutics, and vaccines. Lentiviral vectors are the most efficient vehicles for the delivery of genes or gene silencing sequences stably into cells. Lentigen is a highly collaborative company, co-developing Lentiviral vector-based products across a broad spectrum of bench to clinical applications.